Tailored solutions for complex diseases require systems that replicate patient-specific conditions. Disease modeling and personalized regenerative medicine combine 3D tissue models, patient-derived cells, and bioengineered platforms to predict treatment responses and design targeted therapies. By recreating pathological environments in vitro, researchers can evaluate drug efficacy and explore disease progression mechanisms. This approach reduces dependency on animal models and improves translational relevance. Integration with genomic data, artificial intelligence, and bioprinting allows for highly individualized therapeutic planning. Disease modeling and personalized regenerative medicine enhances precision medicine by aligning cellular behavior with specific genetic and environmental factors, making regenerative interventions more effective and patient-centered.
Title : The era of artificial intelligence (AI) and its use in regenerative medicine
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cells for human disease modelling and potential for tissue repair
Patrizia Ferretti, UCL Great Ormond Street Institute of Child Health, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : The role of gingival fibroblasts in periodontal diseases and regeneration
Katarzyna Gawron, Medical University of Silesia in Katowice, Poland
Title : Personalized and Precision Medicine (PPM): A unique healthcare model via pathology-related modelling and bi-odesign-inspired translational applications for the next gen-eration of human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation